Medicare (United States)

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Retrieved on: 
星期二, 四月 30, 2024

MINNEAPOLIS, Minn., April 29, 2024 /PRNewswire-PRWeb/ -- Zimmerman Reed announced today that the United States and the State of California reached a $7 million settlement with ReNew Health Group LLC, ReNew Health Consulting Services LLC, and its owner-CEO and its COO to resolve False Claims Act allegations filed by Zimmerman Reed's whistleblower clients. ReNew Health, the owner and operator of dozens of nursing facilities throughout California, allegedly submitted millions of dollars of fraudulent claims to Medicare and California Medicaid since March 2020 under a scheme involving a COVID-19 waiver program.

Key Points: 
  • Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program.
  • "This case emphasizes the vital contribution that whistleblowers can make in exposing healthcare fraud," said June Hoidal, chair of Zimmerman Reed's Whistleblower practice.
  • "The courage of our clients who reported improper Medicare and Medicaid claims was instrumental in bringing this case to light and securing a just result."
  • The federal False Claims Act and its state law equivalents empower private citizens to sue on the government's behalf against persons who present false claims for payment under government contracts or programs.

AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing

Retrieved on: 
星期三, 四月 3, 2024

The White House invited AAFA President and CEO, Kenneth Mendez, and Jenna Riemenschneider, AAFA Senior Director of Policy and Advocacy, in recognition of the advocacy group’s work to advance health equity for people with asthma.

Key Points: 
  • The White House invited AAFA President and CEO, Kenneth Mendez, and Jenna Riemenschneider, AAFA Senior Director of Policy and Advocacy, in recognition of the advocacy group’s work to advance health equity for people with asthma.
  • “On behalf of the 27 million people in the United States with asthma, we appreciate the leadership of President Biden and Senator Sanders to bring down costs for asthma treatments.
  • Pricing announcements made in March by some manufacturers of inhalers will mean lower costs and improved access to asthma medicine for many people with asthma starting this June,” stated Mendez.
  • “Lower out-of-pocket costs have the potential to drastically improve asthma health outcomes.

Scammers Bank on You Not Reading Your Medicare Statements

Retrieved on: 
星期三, 三月 27, 2024

Whether you have Original Medicare, which provides Medicare Summary Notices (MSNs), or Medicare Advantage, which provides Explanations of Benefits (EOBs), you should always look at your statements carefully.

Key Points: 
  • Whether you have Original Medicare, which provides Medicare Summary Notices (MSNs), or Medicare Advantage, which provides Explanations of Benefits (EOBs), you should always look at your statements carefully.
  • They summarize Medicare claims, just like credit card or bank statements, and reviewing them could help detect errors or possible fraud.
  • In the past, scammers would send products people didn't want and the charges would show up on Medicare statements.
  • Scammers are hoping people aren't reading their statements so scammers can continue to make big money.

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
星期四, 三月 7, 2024

Myomo recognized revenue on 107 MyoPro units in the fourth quarter of 2023, up 6% compared with the same quarter a year ago.

Key Points: 
  • Myomo recognized revenue on 107 MyoPro units in the fourth quarter of 2023, up 6% compared with the same quarter a year ago.
  • Gross margin for the fourth quarter of 2023 was 65.3%, compared with 65.0% for the fourth quarter of 2022.
  • Operating expenses for the fourth quarter of 2023 were $5.5 million, an increase of 14% compared with the fourth quarter of 2022.
  • Adjusted EBITDA for the fourth quarter of 2023 was $(2.1) million, compared with $(1.9) million for the fourth quarter of 2022.

Therapy Groups Applaud Introduction of the Remove Duplicative Unnecessary Clerical Exchanges Act

Retrieved on: 
星期三, 二月 7, 2024

ALEXANDRIA, Va., Feb. 7, 2024 /PRNewswire/ -- The American Physical Therapy Association, APTA Private Practice, and the American Occupational Therapy Association applaud new legislation that would lower administrative costs for therapy providers to help mitigate continued payment cuts. Introduced in the U.S. House of Representatives by Reps. Don Davis, D-N.C., and Lloyd Smucker, R-Pa., as the Remove Duplicative Unnecessary Clerical Exchanges Act, or the REDUCE Act, this bipartisan legislation would streamline the current plan of care certification requirement under Medicare Part B to reduce administrative burden and paperwork for physical therapists.   

Key Points: 
  • Introduced in the U.S. House of Representatives by Reps. Don Davis, D-N.C., and Lloyd Smucker, R-Pa., as the Remove Duplicative Unnecessary Clerical Exchanges Act, or the REDUCE Act, this bipartisan legislation would streamline the current plan of care certification requirement under Medicare Part B to reduce administrative burden and paperwork for physical therapists.
  • "Physical therapy practices are currently facing many challenges under Medicare, from unsustainable cuts to workforce shortages.
  • The REDUCE Act will allow our members to spend more time with their patients rather than tracking down unnecessary paperwork."
  • The American Physical Therapy Association represents more than 100,000 physical therapists, physical therapist assistants, and physical therapy students nationwide.

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Retrieved on: 
星期五, 一月 19, 2024

A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.

Key Points: 
  • A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.
  • The securities described above were offered pursuant to an effective shelf registration statement on Form S-3 (File No.
  • 333-256159) previously filed with the U.S. Securities and Exchange Commission (the “SEC”).
  • The offering is made only by means of a prospectus supplement and accompanying prospectus, which has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov .

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Retrieved on: 
星期三, 一月 17, 2024

The closing of the offering is expected to occur on or about January 19, 2024, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about January 19, 2024, subject to the satisfaction of customary closing conditions.
  • The Company intends to use the net proceeds from the offering to scale up operations to serve Medicare Part B patients now that CMS has established coverage and proposed pricing for the MyoPro product line.
  • A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.

CorMedix Inc. Announces Commercial and Operational Updates

Retrieved on: 
星期一, 一月 8, 2024

BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced several commercial and operational updates related to its business and anticipated launch of DefenCath®.

Key Points: 
  • BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced several commercial and operational updates related to its business and anticipated launch of DefenCath®.
  • CorMedix formally submitted an HCPCS application for a J-Code to the Center for Medicare and Medicaid Services (CMS) on December 8, 2023 for DefenCath, and CMS has confirmed the application is under review.
  • The Company believes it has sufficient cash, cash equivalents and available resources to fund the commercial launch.
  • The company is working with providers on information needed for their respective formulary processes and expects to provide updates over the upcoming months.

Medicare Advantage vs. Original Medicare: Which is best for you?

Retrieved on: 
星期三, 十一月 15, 2023

Minneapolis, MN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- With Medicare open enrollment underway, it’s helpful for consumers to understand the difference between Original Medicare and Medicare Advantage.

Key Points: 
  • Minneapolis, MN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- With Medicare open enrollment underway, it’s helpful for consumers to understand the difference between Original Medicare and Medicare Advantage.
  • During the open enrollment period, millions of Medicare enrollees can :
    Switch from Original Medicare to Medicare Advantage, or vice versa.
  • Here are a few things to consider when deciding between Original Medicare versus Medicare Advantage, or pairing Original Medicare with a Medigap or Part D plan.
  • Prescription drug costs: Most Medicare Advantage plans include Medicare Part D drug coverage, but if you’re considering a Medicare Advantage plan, it’s a good idea to confirm and make sure.

ACADEMY OF NUTRITION AND DIETETICS URGES CONGRESS: PASS BILL TO INCREASE ACCESS TO NUTRITION CARE

Retrieved on: 
星期三, 十一月 15, 2023

Chicago, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics supports and advocates for expanded access to medical nutrition therapy and additional coverage for more chronic conditions to ensure Medicare beneficiaries can receive the care they need to live healthy lives.

Key Points: 
  • Chicago, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics supports and advocates for expanded access to medical nutrition therapy and additional coverage for more chronic conditions to ensure Medicare beneficiaries can receive the care they need to live healthy lives.
  • Susan Collins (Maine) and Gary Peters (Mich.) and U.S. Reps. Robin Kelly (Ill.) and Jen Kiggans (Va.) for introducing the Medical Nutrition Therapy Act of 2023.
  • The Academy strongly supports passage of the bill, which was originally introduced in 2021.
  • Under the proposed bill, MNT coverage under Medicare Part B would be extended to people with: